Maxymune Therapeutics, Inc.MT
SEC Form D filing

Maxymune Therapeutics, Inc.

Biotech · Series A · Regulation D 506(b) · CA · Filed June 3, 2026

Offering amount
$4.5M
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
June 3, 2026
Signature date
June 3, 2026
CIK
0002058052

Summary

Auto-generated

biotech therapeutics company, $4.5M series-a in CA

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.